A significant decrease in relative gene expression of SOD1 (P < 0.0001) was determined in the endometriosis group (0.004 ± 0.001) and in the endometrial cancer group (0.008 ± 0.001) in comparison with the control group (0.033 ± 0.004). This evidence concerns the gene SOD1 and endometrial cancer.